[1]
“Nature’s Drugs Repositories: Myxobacteria and Actinomycetes as sources of novel antiviral agents against respiratory viruses - Coronavirus, Respiratory Syncytial virus and Influenza virus”, jcbr, vol. 6, no. 1, January-February, pp. 2261–2281, Feb. 2026, doi: 10.54117/64acg226.